Cargando…
MicroRNA as an Important Target for Anticancer Drug Development
Cancer has become the second greatest cause of death worldwide. Although there are several different classes of anticancer drugs that are available in clinic, some tough issues like side-effects and low efficacy still need to dissolve. Therefore, there remains an urgent need to discover and develop...
Autores principales: | Fu, Zhiwen, Wang, Liu, Li, Shijun, Chen, Fen, Au-Yeung, Kathy Ka-Wai, Shi, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425594/ https://www.ncbi.nlm.nih.gov/pubmed/34512363 http://dx.doi.org/10.3389/fphar.2021.736323 |
Ejemplares similares
-
MicroRNA-21: An Emerging Player in Bone Diseases
por: Chen, Chen, et al.
Publicado: (2021) -
Research progress on microRNA in gout
por: Xie, Jing, et al.
Publicado: (2022) -
Natural Product Alantolactone Targeting AKR1C1 Suppresses Cell Proliferation and Metastasis in Non-Small-Cell Lung Cancer
por: Fu, Zhiwen, et al.
Publicado: (2022) -
Pro-Senescence and Anti-Senescence Mechanisms of Cardiovascular Aging: Cardiac MicroRNA Regulation of Longevity Drug-Induced Autophagy
por: Pulakat, Lakshmi, et al.
Publicado: (2020) -
MicroRNA-181a Functions as an Oncogene in Gastric Cancer by Targeting Caprin-1
por: Lu, Qiang, et al.
Publicado: (2019)